Search Within

Sree Bhavani Chalasani

Formats
  1. Journal Article (8)
  2. Meeting Abstract (8)
  3. Book Section (1)
Groups
  1. Department of Medicine (17)
  2. Gastrointestinal Oncology Service (17)
  3. Solid Tumor Oncology Division (17)
  4. Center for Pancreatic Cancer Research (13)
  5. Hematologic Malignancies, Division of (13)
  6. Survivorship Research (13)

More Groups

People
  1. Geoffrey Ku (11)
  2. Yelena Janjigian (10)
  3. David Ilson (9)
  4. Joanne Chou (9)
  5. Marinela Capanu (9)
  6. David Kelsen (7)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (2)
  4. 2022 (2)
  5. 2021 (3)
  6. 2020 (3)

More Years

Publications
  1. Journal of Clinical Oncology (7)
  2. Clinical Cancer Research (3)
  3. Annals of Oncology (1)
  4. Annals of Surgery (1)
  5. Cancer Chemotherapy and Pharmacology (1)
  6. Hepatic Arterial Infusion for Malignancy (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (7)
  2. American Association for Cancer Research (3)
  3. American Medical Association (2)
  4. Oxford University Press (2)
  5. Lippincott Williams & Wilkins (1)
  6. Springer (1)

More Publishers

Results (17)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Durvalumab (D) and PET-directed chemoradiation (CRT) after induction FOLFOX for esophageal adenocarcinoma
    Meeting Abstract

    Ly, M.; Molena, D.; Sihag, S.; Wu, A. J. C.; Shah, P. M.; Gu, P.; Sugarman, R.; Maron, S. B.; Chalasani, S. B.; Shcherba, M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Regorafenib in combination with first-line chemotherapy for metastatic esophagogastric cancer
    Journal Article

    Moy, R. H.; Dos Santos Fernandes, G.; Jonsson, P.; Chou, J. F.; Basunia, A.; Ku, G. Y.; Chalasani, S. B.; Boyar, M. S.; Goldberg, Z.; Desai, A. M.; more...
    The Oncologist (2020)

    Fulltext@MSK | Save
  • Homologous recombination deficiency (HRD): A biomarker for first-line (1L) platinum in advanced pancreatic ductal adenocarcinoma (PDAC)
    Meeting Abstract

    Park, W.; Wong, W.; Yu, K. H.; Varghese, A. M.; Riaz, N.; Balachandran, V. P.; El Dika, I. H.; Raj, N. P.; Khalil, D.; Ku, G. Y.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Efficacy of combined VEGFR1-3, PDGFα/β, and FGFR1-3 blockade using nintedanib for esophagogastric cancer
    Journal Article

    Won, E.; Basunia, A.; Chatila, W. K.; Hechtman, J. F.; Chou, J. F.; Ku, G. Y.; Chalasani, S. B.; Boyar, M. S.; Goldberg, Z.; Desai, A. M.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Assessment of a watch-and-wait strategy for rectal cancer in patients with a complete response after neoadjuvant therapy
    Journal Article

    Smith, J. J.; Strombom, P.; Chow, O. S.; Roxburgh, C. S.; Lynn, P.; Eaton, A.; Widmar, M.; Ganesh, K.; Yaeger, R.; Cercek, A.; more...
    JAMA Oncology (2019)

    Fulltext@MSK | Save
  • Clinical characterization of pancreatic ductal adenocarcinomas (PDAC) with mismatch repair (MMR) gene mutations
    Meeting Abstract

    Hu, Z. I.; Varghese, A. M.; Shia, J.; Zervoudakis, A.; Lowery, M. A.; Yu, K. H.; Chalasani, S. B.; Robson, M. E.; Stadler, Z. K.; Caron, P.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase II study of FOLFOX plus regorafenib (REGO) in patients with unresectable or metastatic esophagogastric (EG) cancer
    Meeting Abstract

    Janjigian, Y. Y.; Ku, G. Y.; Chou, J. F.; Capanu, M.; Siebel, M.; Chalasani, S. B.; Boyar, M. S.; Goldberg, Z.; Desai, A. M.; Kelsen, D. P.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save